A couple of companies I own stock in reported over the last week or so, so I thought I’d do a quick post on a pretty straightforward one – MacMahon Holdings.
Here’s the annual report. It’s a mining services company, so you’d expect it to be pretty cheap.
Current market cap is $102m. Net cash is $74m.
So you’re buying all the equipment and contracts etc. for $28m. The company has PPE of $141m, after $202m of impairment charges this year.
So you’re buying PPE at about 20% of its reported value after a pretty huge writedown.
“Underlying profit” for FY2015 was $10m.
Cheap enough for me, but it could be a rough ride for a year or two.
Edited to add: Insiders bought 3.2m shares over the last year, although in total this is probably only about $200k worth.
Average performance in the first half of 2015. 0.1% increase for my USA portfolio. My return was much higher in NZD terms, but that is not counted for my benchmarking purposes.
My NZ/Aus portfolio was up 2.7%.
In other news, I sat CFA Level 3 and found it quite tough. We’ll see results in August.
Someone should give this guy some money to start a fund already.
This took too long to get around to doing. But I’ve got a new baby and am studying for Level 3 CFA as well as working full time.
Anyway, here are the numbers:
As you can see, a disappointing 2014, and total underperformance since 2012. Cash balances in my NZ portfolio dragged me down, and great recent performance from Tower (TWR) isn’t in the data yet.
My USA portfolio is just mislabelled now, as the largest position is in GVAL, a global value ETF and a poor performer in 2014 (but well performing in 2015 so far).
I am disappointed in the underperformance relative to the benchmark, but obviously very happy with the absolute performance. To me, it reinforces how difficult it is to both outperform with security selections, and to time the market. I don’t actively try to time the market, but cash balances are a function of how many good opportunities I see, and so I implicitly am timing the market relative to a passive portfolio that is 100% invested.
I have moved a lot of my portfolio to value-tilted ETFs. If I see particular opportunities I will still post, but as I noted above, I’m pretty busy these days. I’ll continue to update performance numbers to see if my value ETFs + individual stocks outperform the broader market.
Edit: Originally I understated my 2014 NZ performance because I misread my spreadsheet and substituted second half 2014 performance for total 2014 performance. The numbers above are now corrected.
With dividends, my New Zealand/Australian portfolio was up 9.7% for first half of 2014. The New Zealand index was up 7.9%. My best performers were Telecom and Chorus.
My USA portfolio was up 4.8%. The S&P500 was up 8%. My best performer was Apple.
I’m happy with the performance, given that the figures above include not insignificant cash balances in a rising market. It’s also not quite right to call my USA portfolio a “USA portfolio”, as now the largest position is in the Global Value ETF (GVAL)
Here’s a table showing my very modest outperformance since inception:
If you’re looking for real outperformance, check out my (as always) favourite blogger: alphavulture!
CFA study is finally over for the year.
I’ve made a few portfolio changes since my last post.
I sold most of my Tenon after more and more disappointing homestart data out of the USA. Given it was such a big part of the thesis, and I was sure it was turning, I decided that me being wrong on that basically eroded my confidence in the thesis. I made a small gain as the shares traded slightly upward from purchase.
I sold Apple. It was up 50% from my purchase price, and I bought it because it just seemed so cheap. At $90 (post split), it doesn’t seem nearly as cheap any more (although still cheap).
Tower posted some good results, and so did (most surprisingly) Kirkcaldies.
Trademe got a lot cheaper, and I built a (for my portfolio) largish position. I may write a longer post on Trademe later. It’s not a super cheap stock, but given the business quality, it’s looking relatively cheap if you assume they can achieve any real growth (difficult, but not impossible).
I don’t have time to write up a proper post, as I’m behind in CFA level 2 study.
But I bought Tenon (TEN on the NZ stock exchange). Tenon is a wood products processing, marketing and distribution business.
Here are some brief notes:
- Director’s wife bought 50,151 shares for $68 000 In March 2014.
- Planned resumption of shareholder cash returns in second half of calendar 2014.
- Intending to increase the company’s equity exposure to US investors.
- Edison analyst report values Tenon at mid-point of $2.40 per share (current price of $1.40)
- Third Avenue Value Fund is a big (18%) shareholder.
- Bottom line profitability expected in second half of 2014 fiscal year (before restructuring costs).
- EBITDA of $5 million recorded in most recent year.
- Targeting $10 m EBITDA in fiscal 2014.
- Mid-cycle EBITDA (assumes 1.7 million housing starts and NZD/USD of 70cents) of $45 million.
Basically, this company is levered to US homebuilding, but has been left behind in the runup of those stocks. That could be because the float is limited, the stock is only listed in New Zealand, etc.
It looks pretty cheap, so I bought a smallish position. This is a useful summary of the latest annual meeting.
Back to study now!
The discount from NAV shrunk from 20% to about 10%, and the NAV rose a bit from when I purchased.
Given that I didn’t have particular views in either direction about fund manager skill, a 10% discount seemed appropriate given the size of the fund (small) and its expense ratio. Note that a much larger discount would have been appropriate had the fund not been paying out 8% of its NAV as dividends and buying back ~5% of its own shares each year.
I sold all of my shares over the last two months. It’s a 35% IRR, but a lot of that was due to the NAV rising. Given my thesis was almost entirely about the discount, the rising NAV was a lucky bonus.
I would buy again if the discount got to 20% again.